These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6174141)

  • 1. Plasma betathromboglobulin and serum fragment E in acute partial stroke.
    de Boer AC; Turpie AG; Butt RW; Duke RJ; Bloch RF; Genton E
    Br J Haematol; 1982 Feb; 50(2):327-34. PubMed ID: 6174141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma beta-thromboglobulin, fibrinopeptide A and B beta 15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment.
    Douglas JT; Blamey SL; Lowe GD; Carter DC; Forbes CD
    Thromb Haemost; 1985 Apr; 53(2):235-8. PubMed ID: 2410995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The platelet release reaction in cardiovascular disease: evaluation of plasma betathromboglobulin as a marker of a prothrombotic state.
    Pumphrey CW; Dawes J
    Eur Heart J; 1984 Oct; 5 Suppl D():7-11. PubMed ID: 6083867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-thromboglobulin in antecubital vein blood in relation to history of a stroke.
    Dewar HA; Marshall T; Weightman D; Boon PJ
    Age Ageing; 1980 Nov; 9(4):262-6. PubMed ID: 6163337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-thromboglobulin levels in relation to myocardial infarction--preliminary observations.
    Simmonds JP; O'Malley BP; Maskill MR; O'Connor JF; Burridge DJ
    Acta Haematol; 1980; 64(3):172-5. PubMed ID: 6160710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
    Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
    Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of betathromboglobulin and platelet factor 4 in peripheral vascular disease.
    Blättler W; Diener R; Haeberli A; Straub PW
    Vasa Suppl; 1984; 12():75-80. PubMed ID: 6207678
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemistry, measurement, and clinical significance of platelet specific proteins.
    de Boer AC; Genton E; Turpie AG
    Crit Rev Clin Lab Sci; 1982; 18(2):183-211. PubMed ID: 6185275
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum fragment E and plasma beta-thromboglobulin in patients with acute pulmonary embolism and non-thromboembolic lung diseases.
    Farrell RJ; Duffy MJ; Duffy GJ
    Thromb Res; 1982 Jul; 27(2):231-4. PubMed ID: 6182626
    [No Abstract]   [Full Text] [Related]  

  • 10. beta-Thromboglobulin, platelet production time and pletelet function in vascular disease.
    Cella G; Zahavi J; de Haas HA; Kakkar VV
    Br J Haematol; 1979 Sep; 43(1):127-36. PubMed ID: 92336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of fibrinogen derivatives in plasma in human renal failure.
    Lane DA; Ireland H; Knight I; Wolff S; Kyle P; Curtis JR
    Br J Haematol; 1984 Feb; 56(2):251-60. PubMed ID: 6229269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma fibrinopeptide A and beta-thromboglobulin in major bacterial infections.
    van Hulsteijn H; Fibbe W; Bertina R; Briët E
    Thromb Haemost; 1982 Dec; 48(3):247-9. PubMed ID: 6187081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of coagulation and fibrinolytic systems following stroke.
    Lane DA; Wolff S; Ireland H; Gawel M; Foadi M
    Br J Haematol; 1983 Apr; 53(4):655-8. PubMed ID: 6219694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of the platelet release reaction in the blood compatibility assessment of polymers.
    Bowry SK; Courtney JM; Prentice CR; Douglas JT
    Biomaterials; 1984 Sep; 5(5):289-92. PubMed ID: 6207864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of beta-thromboglobulin during storage of platelet concentrates.
    Snyder EL
    Vox Sang; 1981; 40 Suppl 1():115-6. PubMed ID: 6170171
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction.
    Tombul T; Atbas C; Anlar O
    J Clin Neurosci; 2005 May; 12(4):429-34. PubMed ID: 15925775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-thromboglobulin plasma levels in common migraine.
    Violi F; Iuliano L; Alessandri C; Frattaroli S; Bonavita MS
    Thromb Haemost; 1984 Apr; 51(2):295. PubMed ID: 6204397
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma beta-thromboglobulin in patients with valvular heart disease with or without valve replacement: relationship with thromboembolic accidents.
    Conard J; Horellou MH; Baillet M; Terrier E; Houllegate JM; Farah E; Samama M; Acar J
    Eur Heart J; 1984 Oct; 5 Suppl D():13-8. PubMed ID: 6083866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4). Detection of an in vivo thrombocyte activation].
    Hellstern P; Köhler M; Wenzel E
    ZFA (Stuttgart); 1981 May; 57(15):1136-41. PubMed ID: 6167083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.